G1 Therapeutics.

PositionRTP

G1 Therapeutics raised [dollar]108.6 million in an initial public offering. The cancer drugmaker was spun out of UNC Chapel Hill in 2008. Investors include Hatteras Venture Partners and...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT